[ad_1] This year, I got in touch with several longevity experts to talk about living a long, healthy life — and to learn more about their own personal practices.”Almost everything I recommend to my patients, I do myself,” said Dr. Frank Lipman, a doctor of functional medicine who researches longevity.Many of Lipman’s suggestions for good health aligned with what I heard from Dr. Andrea Maier, a health and longevity expert with nearly 25 years of experience in geroscience, Valter Longo, who’s been studying longevity in Italy for about 20 years, and the popular researcher Dan Buettner.Here’s what I learned from some…
Author: user
[ad_1] CELH Investors with Losses Encouraged to Contact the Firm San Francisco, California–(Newsfile Corp. – December 25, 2024) – Celsius Holdings (NASDAQ:), Inc. (NASDAQ: CELH) and certain of its C-Suite officers are embroiled in a securities class action lawsuit, claiming they misrepresented and concealed crucial information about the company’s financial performance, especially concerning its key customer, PepsiCo (NASDAQ:). Hagens Berman is investigating the allegations and urges investors in Celsius who purchased shares and suffered substantial losses to submit your losses now. Class Period: Feb. 29, 2024 – Sept. 4, 2024Lead Plaintiff Deadline: Jan. 21, 2025Visit: www.hbsslaw.com/investor-fraud/celhContact the Firm Now: CELH@hbsslaw.com844-916-0895…
[ad_1] Here’s How You Can Earn $100 In Passive Income By Investing In Gilead Sciences Stock Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical company, discovers, develops and commercializes medicines to address unmet medical needs in the United States, Europe and internationally. It will report its Q4 2024 earnings on Feb. 11, 2025. Wall Street analysts expect the company to post an EPS of $1.55, down from $1.72 in the year-ago period. According to data from Benzinga Pro, quarterly revenue is expected to be $7.14…
[ad_1] San Francisco, California–(Newsfile Corp. – December 25, 2024) – On December 9, 2024, just months after conducting an initial public offering in September 2024, BioAge Labs, Inc. (NASDAQ: BIOA) made the startling announcement that it was discontinuing a Phase 2 study for its lead product, azelaprag, intended to treat metabolic diseases such as obesity. Hagens Berman has opened an investigation and urges investors in BioAge who purchased shares in the company’s IPO or on the open market and suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/bioaContact the Firm Now: BIOA@hbsslaw.com844-916-0895 BioAge Labs, Inc. (BIOA) Investigation: The investigation…
[ad_1] UNITED STATES – DECEMBER 19: Robert F. Kennedy Jr., President-elect Donald Trump’s pick to be … [+] secretary of Health and Human Services, is seen in the U.S. Capitol on Thursday, December 19, 2024. (Tom Williams/CQ-Roll Call, Inc via Getty Images)CQ-Roll Call, Inc via Getty Images I think it’s clear by now that Trump 2.0 is going to look different from Trump 1.0. Some areas, like tariffs, look similar to the first time around (though we expect more of them in the second term). Others are totally different. (Hands up if you had a potential crackdown on processed food…
[ad_1] It’s no secret that growth investing mastermind Cathie Wood expects big things from Bitcoin (CRYPTO: BTC). The Ark Invest fund manager started talking about crypto before she was a household name, and has recently doubled down on her bullish projections again. In a Bloomberg TV interview last Thursday, Wood reiterated a Bitcoin price target of $1.0 to $1.5 million by the year 2030. But that’s not the whole story. The cool part of Cathie Wood’s Bitcoin coverage is that she keeps explaining her investment thesis in greater detail over time. Last week’s interview was no exception. So let’s check…
[ad_1] Image source: Getty Images I think investors looking to earn a second income should keep an eye on Unilever (LSE:ULVR) shares. A portfolio of strong brands in a defensive sector has a decent chance of providing durable dividends. The trouble is, the share price climbing this year has caused the dividend yield to sink. But there’s a chance things might be different in 2025 and I think investors should aim to be ready. Dividends In 2023, the dividend yield on Unilever shares got close to 4%. Before that, it had been over 10 years since investors last had the…
[ad_1] Company announcement “ No. 53 / 2024 Transactions in Zealand Pharma (NASDAQ:) shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, December 25, 2024 “ Zealand Pharma A/S (Zealand) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand Pharma’s shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons and hereby publishes the information on such transactions. Please see the attached file(s). About Zealand Pharma A/S Zealand Pharma…
[ad_1] The seventh most highly read story from PCD in 2024 revolved around reporting on Novant as a nonprofit hospital that also invests in offshore tax havens. (Port City Daily/Amy Passaretti Willis) WILMINGTON — Port City Daily continues to count down its most popularly read stories of 2024, as assessed by analytics. READ MORE: No. 8 Most Read Story of 2024: Edward Teach Brewery charged by ALE The seventh most highly read revolved around reporting on Novant as a nonprofit hospital that also invests in offshore tax havens. In April, Port City Daily ran a piece about one of the…
[ad_1] MOSCOW (Reuters) – Russia’s inflation has reached 9.5% this year, according to new weekly data showing that the consumer price index rose by 0.33% in the week leading up to Dec. 23, the statistical agency Rosstat reported on Wednesday. This data follows the central bank’s unexpected decision last week to maintain its key interest rate at 21%. The regulator said recent tightening has created conditions conducive to reducing inflation towards its target of 4%. The agency indicated that seasonally volatile prices for fruit and vegetables contributed significantly to the overall increase, with cucumber prices rising by 8.3% and tomato…